Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Bruker Corp (NASDAQ: BRKR) closed the day trading at $30.43 down -2.34% from the previous closing price of $31.16. In other words, the price has decreased by -$2.34 from its previous closing price. On the day, 3.94 million shares were traded. BRKR stock price reached its highest trading level at $31.19 during the session, while it also had its lowest trading level at $30.225.
Ratios:
For a better understanding of BRKR, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 50.18 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 93.65. For the most recent quarter (mrq), Quick Ratio is recorded 0.70 and its Current Ratio is at 1.61. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 1.32.
On December 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $72.
On December 10, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $66.UBS initiated its Neutral rating on December 10, 2024, with a $66 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 06 ’25 when LAUKIEN FRANK H bought 2,608 shares for $38.36 per share. The transaction valued at 100,043 led to the insider holds 38,462,171 shares of the business.
Bures Thomas bought 500 shares of BRKR for $23,698 on Mar 10 ’25. The Chief Accounting Officer now owns 3,472 shares after completing the transaction at $47.40 per share. On Feb 18 ’25, another insider, LAUKIEN FRANK H, who serves as the PRESIDENT & CEO of the company, bought 20,000 shares for $50.92 each. As a result, the insider paid 1,018,330 and bolstered with 38,459,563 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BRKR now has a Market Capitalization of 4616809472 and an Enterprise Value of 7058420224. As of this moment, Bruker’s Price-to-Earnings (P/E) ratio for their current fiscal year is 58.08, and their Forward P/E ratio for the next fiscal year is 12.86. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 14.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.34 while its Price-to-Book (P/B) ratio in mrq is 2.56. Its current Enterprise Value per Revenue stands at 2.05 whereas that against EBITDA is 12.659.
Stock Price History:
The Beta on a monthly basis for BRKR is 1.24, which has changed by -0.4963588 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, BRKR has reached a high of $72.94, while it has fallen to a 52-week low of $30.19. The 50-Day Moving Average of the stock is -22.60%, while the 200-Day Moving Average is calculated to be -35.97%.
Shares Statistics:
Over the past 3-months, BRKR traded about 2.95M shares per day on average, while over the past 10 days, BRKR traded about 4297610 shares per day. A total of 151.72M shares are outstanding, with a floating share count of 103.12M. Insiders hold about 32.03% of the company’s shares, while institutions hold 80.15% stake in the company. Shares short for BRKR as of 1752537600 were 9450855 with a Short Ratio of 3.20, compared to 1749772800 on 9884952. Therefore, it implies a Short% of Shares Outstanding of 9450855 and a Short% of Float of 13.469999999999999.
Dividends & Splits
BRKR’s forward annual dividend rate is 0.20, up from 0.2 a year ago. Against a Trailing Annual Dividend Yield of 0.006418485The stock’s 5-year Average Dividend Yield is 0.3.
Earnings Estimates
A detailed examination of Bruker Corp (BRKR) is currently in progress, with 12.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.87, with high estimates of $0.92 and low estimates of $0.83.
Analysts are recommending an EPS of between $2.03 and $1.95 for the fiscal current year, implying an average EPS of $1.98. EPS for the following year is $2.42, with 13.0 analysts recommending between $2.83 and $2.09.
Revenue Estimates
11 analysts predict $849.33M in revenue for the current quarter. It ranges from a high estimate of $859.3M to a low estimate of $838.14M. As of the current estimate, Bruker Corp’s year-ago sales were $864.4MFor the next quarter, 11 analysts are estimating revenue of $1B. There is a high estimate of $1.02B for the next quarter, whereas the lowest estimate is $972.3M.
A total of 11 analysts have provided revenue estimates for BRKR’s current fiscal year. The highest revenue estimate was $3.47B, while the lowest revenue estimate was $3.42B, resulting in an average revenue estimate of $3.45B. In the same quarter a year ago, actual revenue was $3.37BBased on 11 analysts’ estimates, the company’s revenue will be $3.51B in the next fiscal year. The high estimate is $3.58B and the low estimate is $3.45B.
